Kyntheum Европейски съюз - български - EMA (European Medicines Agency)

kyntheum

leo pharma a/s - brodalumab - псориазис - Имуносупресори - Кентеум е показан за лечение на умерен до тежък плаков псориазис при възрастни пациенти, които са кандидати за системна терапия.

Crysvita Европейски съюз - български - EMA (European Medicines Agency)

crysvita

kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - Лекарства за лечение на костни заболявания - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.

Imfinzi Европейски съюз - български - EMA (European Medicines Agency)

imfinzi

astrazeneca ab - durvalumab - Карцином, недребноклетъчен белодроб - Антинеопластични средства - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).

Gamifant Европейски съюз - български - EMA (European Medicines Agency)

gamifant

swedish orphan biovitrum ab (publ) - emapalumab - immune system diseases - gamifant is indicated for the treatment of paediatric patients aged under 18 years with primary haemophagocytic lymphohistiocytosis (hlh).

APOVOMIN 3 mg/ml инжекционен разтвор за кучета 3,00 mg България - български - БАБХ (Българска агенция по безопасност на храните)

apovomin 3 mg/ml инжекционен разтвор за кучета 3,00 mg

dechra regulatory b.v. - Апоморфина хидрохлорид полугидрат - инжекционен разтвор - 3,00 mg - кучета

OPHTOCYCLINE 10 mg/g eye ointment for dogs, cats and horses 10.0 mg/g България - български - БАБХ (Българска агенция по безопасност на храните)

ophtocycline 10 mg/g eye ointment for dogs, cats and horses 10.0 mg/g

le vet beheer b.v. - Хлортетрациклина хидрохлорид - маз за очи - 10.0 mg/g - коне, котки, кучета

REPOSE 500 mg/ml solution for injection 500 mg/ml България - български - БАБХ (Българска агенция по безопасност на храните)

repose 500 mg/ml solution for injection 500 mg/ml

le vet beheer b.v. - Натриев Пентобарбитал - инжекционен разтвор - 500 mg/ml - говеда, гризачи, зайци, кози, коне, котки, кучета, норки, овце, прасета